FDA Continues Nanotech Policy Development With September Meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA will hold a meeting next month to hear opinions on new guidelines in development on nanotechnology products, the agency announced Aug. 7 in the Federal Register